Companies/Core One Labs Inc.

Company profile

Core One Labs Inc.

OTC: CLABF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Vancouver, BCReports USD

#947 of 1,394 Healthcare companies by revenue45th-percentile growth

EA Score

——

FH —DQ —GM —SS 42

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, workforce scale · ↓ market scale, growth stability

Methodology →

Revenue TTM

$147.3k

Rev growth YoY (TTM)

-70.2%

Net income (FY)

-$12.3M

Employees

192

Market cap

$471

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$352.4k458.5k CAD2022

Net income-$12.3M-16.0M CAD2022

Operating income-$6.0M-7.8M CAD2022

Total assets$6.0M8.1M CAD2022

Liabilities$1.0M1.4M CAD2022

Equity$5.0M6.7M CAD2022

Revenue trend

FY2017 – FY2022 · USD

$147.2k

FY17

$3.1M

FY18

$3.8M

FY19

FY20

$344.3k

FY21

$352.4k

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Core One Labs Inc. booked $352.4k in FY2022 revenue, growing 2.4% year over year — about the middle of the pack among Healthcare companies we track, at a -3485.4% net margin.

Peers · Healthcare

Strategic Global Investments, Inc.——Verde Science, Inc.——Neptune Wellness Solutions Inc.——Cannabiz Mobile, Inc.——

Key facts

CEOGareth Manderson

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersVancouver, BC

ExchangeOTC: CLABF

Employees192

IPO date2015-06-25

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.